Price discrimination by pharmaceutical companies across Central American countries

International Journal of Pharmaceutical and Healthcare Marketing

Volumn 3, Issue 2, 2009, Pages 118-136

  Rojas, Mariano ^a  

^a Facultad Latinoamericana de Ciencias Sociales Mexico   (Mexico)

Author keywords

Central America; Drugs; Pharmaceuticals industry; Prices; Pricing policy

Indexed keywords

EID: 68949181907     PISSN: 17506123     EISSN: None     Source Type: Journal    
DOI: 10.1108/17506120910971704     Document Type: Article

References (34)

1. Andersson, F. (1993), Methodological aspects of international drug price comparisons, Pharmacoeconomics, Vol. 4, pp. 247-56.
2. Baumol, W.J. and Bradford, D.F. (1970), Optimal departures from marginal cost pricing, American Economic Review, Vol. 60 No. 3, pp. 265-83.
3. Borenstein, S. (1985), Price discrimination in free-entry markets, Rand Journal of Economics, Vol. 16 No. 3, pp. 380-97.
4. Carlton, D.W. and Perloff, J.M. (1989), Modern Industrial Organization, Harper Collins, New York, NY.
5. Cocks, D. and Virts, J. (1974), Pricing behavior of the ethical pharmaceutical industry, Journal of Business, Vol. 47 No. 3, pp. 349-62.
6. Danzon, P.M. (1996), The uses and abuses of international price comparisons, in Helms, R.B. (Ed.), Competitive Strategies in the Pharmaceutical Industry, The American Enterprise Institute Press, Washington, DC, pp. 85-106.
7. Danzon, P.M. (1997a), Pharmaceutical Price Regulation: National Policies versus Global Interests, The American Enterprise Institute Press, Washington, DC.
8. Danzon, P.M. (1997b), Price discrimination for pharmaceuticals: welfare effects in the US and EU, International Journal of the Economics of Business, Vol. 4, pp. 301-21.
9. Danzon, P.M. (1997c), Trade and price differentials for pharmaceuticals: policy options, Research Paper, Office of Health Economics, London.
10. Danzon, P.M. and Chao, L.W. (2000), Prices, competition and regulation in pharmaceuticals: a cross-national comparison, working paper, Office of Health Economics, London.
11. Danzon, P.M. and Kim, J.D. (1996), Price indexes for pharmaceuticals: how accurate are international comparisons?, working paper, The Wharton School, University of Pennsylvania, Philadelphia, PA.
12. Danzon, P.M. and Kim, J.D. (1997), International price comparisons for pharmaceuticals, working paper, The Wharton School, University of Pennsylvania, Philadelphia, PA.
13. Danzon, P.M. and Towse, A. (2000), Differential pricing for pharmaceuticals: reconciling access, R&D and patents, International Journal of Health Care Finance and Economics, Vol. 3, pp. 183-205.
14. Dhar, S.K. and Hoch, S.J. (1996), Price discrimination using in-store merchandising, Journal of Marketing, Vol. 60 No. 1, pp. 17-30.
15. Dickson, M. and Redwood, H. (1998), Pharmaceutical reference prices: how do they work in practice?, Pharmacoeconomics, Vol. 14 No. 5, pp. 471-9.
16. ECLA (2002), Anuario Estadístico de América Latina y el Caribe 2002, Economic Commission for Latin America, Santiago.
17. Griliches, Z. and Cockburn, I. (1994), Generics and new goods in pharmaceutical price indexes, American Economic Review, Vol. 84 No. 5, pp. 1213-32.
18. Gual, J. (1993), An econometric analysis of price differentials in the EEC automobile market, Applied Economics, Vol. 25 No. 5, pp. 599-607.
19. Hay, D and Morris, D. (1991), Industrial Economics and Organization: Theory and Evidence, Oxford University Press, Oxford.
20. Khan, R. and Jain, D. (2005), An empirical analysis of price discrimination mechanisms and retailer profitability, Journal of Marketing Research, Vol. 42 No. 4, pp. 516-24.
21. Knetter, M. (1993), International comparisons of price-to-market behavior, American Economic Review, Vol. 83 No. 3, pp. 473-86.
22. Martin, S. (2002), Advanced Industrial Economics, Blackwell, London.
23. Phlips, L. (1983), The Economics of Price Discrimination, Cambridge University Press, Cambridge.
24. Pigou, A.C. (1920), The Economics of Welfare, Macmillan, London.
25. Productivity Commission (2001), International pharmaceutical price differences, Research Report, AusInfo, Canberra.
26. Rojas, M. (2005), Price differences in identical drugs across Central American countries, Journal of Pharmaceutical Finance, Economics and Policy, Vol. 14 No. 1, pp. 17-37.
27. Scherer, F.M. and Ross, D. (1990), Industrial Market Structure and Economic Performance, Houghton Mifflin Company, Boston, MA.
28. Shy, O. (1995), Industrial Organization, MIT Press, Cambridge, MA.
29. Tellis, G.J. (1986), Beyond the many faces of price: an integration of pricing strategies, Journal of Marketing, Vol. 50 No. 4, pp. 146-60.
30. Tirole, J. (1998), The Theory of Industrial Organization, MIT Press, Cambridge, MA.
31. Varian, H. (1980), A model of sales, American Economic Review, Vol. 70 No. 4, pp. 651-9.
32. Varian, H. (1989), Price discrimination, in Schmalensee, R. and Willig, R. (Eds), Handbook on Industrial Organization, North-Holland, Amsterdam, pp. 597-654.
33. Verboven, F. (1996), International price discrimination in the European car market, Rand Journal of Economics, Vol. 27 No. 2, pp. 240-68.
34. Viswanathan, S., Kuruzovich, J., Gosain, S. and Agarwal, R. (2007), Online infomediaries and price discrimination: evidence from the automotive retailing sector, Journal of Marketing, Vol. 71 No. 3, pp. 89-107.